ALNY vs SRCE · P/E 76, rev $1.29B vs P/E 12, rev $257.2M
Alnylam Pharmaceuticals Inc (ALNY) versus 1st Source Corporation (SRCE) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
1st Source Corporation (SRCE) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported SRCE revenue for 2026-06-30 was $257.2M. Net income was $87.5M. SRCE currently screens at market cap $1.61B and trailing P/E 11.5.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. SRCE currently screens at market cap $1.61B and trailing P/E 11.5.
Not investment advice. Open the ALNY and SRCE stock pages for the full models.
Not investment advice.